ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 25 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,324 | -39.9% | 838 | 0.0% | 0.00% | – |
| Q2 2023 | $2,202 | -27.8% | 838 | 0.0% | 0.00% | – |
| Q1 2023 | $3,050 | +19.7% | 838 | +29.5% | 0.00% | – |
| Q4 2022 | $2,547 | -15.1% | 647 | -13.7% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 750 | -38.3% | 0.00% | – |
| Q2 2022 | $5,000 | -85.3% | 1,215 | -80.3% | 0.00% | – |
| Q1 2022 | $34,000 | +61.9% | 6,163 | +87.0% | 0.00% | – |
| Q4 2021 | $21,000 | -41.7% | 3,296 | -10.6% | 0.00% | – |
| Q3 2021 | $36,000 | +350.0% | 3,685 | +310.8% | 0.00% | – |
| Q2 2021 | $8,000 | -77.1% | 897 | -71.4% | 0.00% | – |
| Q1 2021 | $35,000 | +34.6% | 3,135 | +0.4% | 0.00% | – |
| Q4 2020 | $26,000 | – | 3,123 | +11053.6% | 0.00% | – |
| Q4 2019 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |